| Characteristic | Revenue in million U.S. dollars |
|---|---|
| Illumina | 2,752 |
| Thermo Fisher Scientific | 418.4 |
| BGI Genomics | 332.3 |
| Agilent Technologies** | 230 |
| Qiagen | 115 |
| Macrogen | 95.4 |
| Pacific Biosciences of California | 93.5 |
| Genewiz*** | 83.1 |
| 10x Genomics | 71 |
| Oxford Nanopore Technologies*** | 6.3 |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
More information
Region
Worldwide
Survey time period
2017
Supplementary notes
Revenues are either companywide for companies entirely focused on the segment, or, for companies with broader operations, figures for sequencing-related business segments.Â
Not included are corporate giants — companies that provide workflow solutions around sequencing, though not sequencing technologies or services per se — and which do not break out sequencing revenues, like for example: Roche, Becton Dickinson, PerkinElmer, etc.
** Estimate.
*** 2016 revenue.
Citation formats
